Search details
1.
Targeting cellular cathepsins inhibits hepatitis E virus entry.
Hepatology
; 2024 May 10.
Article
in English
| MEDLINE | ID: mdl-38728662
2.
Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients.
Hepatology
; 78(6): 1882-1895, 2023 Dec 01.
Article
in English
| MEDLINE | ID: mdl-37334496
3.
Phosphorylation of SARS-CoV-2 Orf9b Regulates Its Targeting to Two Binding Sites in TOM70 and Recruitment of Hsp90.
Int J Mol Sci
; 22(17)2021 Aug 26.
Article
in English
| MEDLINE | ID: mdl-34502139
4.
Productive infection of primary human hepatocytes with SARS-CoV-2 induces antiviral and proinflammatory responses.
Gut
; 2023 Dec 12.
Article
in English
| MEDLINE | ID: mdl-38123990
5.
The pivotal role of CD8+ T cells in hepatitis E virus infection.
J Hepatol
; 77(4): 909-911, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35977612
6.
Host determinants and responses underlying SARS-CoV-2 liver tropism.
Curr Opin Microbiol
; 79: 102455, 2024 Mar 23.
Article
in English
| MEDLINE | ID: mdl-38522265
7.
Halogenated Rocaglate Derivatives: Pan-antiviral Agents against Hepatitis E Virus and Emerging Viruses.
J Med Chem
; 67(1): 289-321, 2024 Jan 11.
Article
in English
| MEDLINE | ID: mdl-38127656
8.
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment.
JHEP Rep
; 6(3): 100989, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38434938
9.
Janus kinase-inhibition modulates hepatitis E virus infection.
Antiviral Res
; 217: 105690, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37517633
10.
Hepatitis E virus species barriers: seeking viral and host determinants.
Curr Opin Virol
; 56: 101274, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-36283248
11.
Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replication.
Antiviral Res
; 204: 105359, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35728703
12.
In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant.
Front Immunol
; 13: 1062210, 2022.
Article
in English
| MEDLINE | ID: mdl-36618413
13.
In Vitro Lung Models and Their Application to Study SARS-CoV-2 Pathogenesis and Disease.
Viruses
; 13(5)2021 04 28.
Article
in English
| MEDLINE | ID: mdl-33925255
14.
Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma.
Cancers (Basel)
; 13(22)2021 Nov 22.
Article
in English
| MEDLINE | ID: mdl-34831021
15.
Antiviral Effect of Budesonide against SARS-CoV-2.
Viruses
; 13(7)2021 07 20.
Article
in English
| MEDLINE | ID: mdl-34372616
16.
Clinical Course of Infection and Cross-Species Detection of Equine Parvovirus-Hepatitis.
Viruses
; 13(8)2021 07 26.
Article
in English
| MEDLINE | ID: mdl-34452320
17.
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks.
J Vis Exp
; (160)2020 06 26.
Article
in English
| MEDLINE | ID: mdl-32658206
18.
Functional Significance of Conserved Cysteines in the Extracellular Loops of the ATP Binding Cassette Transporter Pdr11p.
J Fungi (Basel)
; 7(1)2020 Dec 22.
Article
in English
| MEDLINE | ID: mdl-33375075
19.
Be Aware of the Dog: Tacrolimus Usage and Chronic Hepatitis E Virus Infections.
Kidney Int Rep
; 9(5): 1160-1162, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38707829
Results
1 -
19
de 19
1
Next >
>>